GlassScriptPhysician profile
John L Boone
NPI 1609035781
$669.36
in general payments reported to CMS, 2019-2025
12 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $203 · 2023: $55.19 · 2024: $275 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $123.75 | 2020 | |
| Medtronic, INC. | $114.66 | 2024-2025 | Nuvent |
| Smith+Nephew, INC. | $85.65 | 2023-2024 | Tula |
| Preceptis Medical, INC. | $82.75 | 2023-2024 | Hummingbird Tympanostomy Tube System |
| Intersect Ent, INC. | $67.26 | 2020 | |
| Aerin Medical INC. | $40.63 | 2020-2024 | |
| Itamar Medical INC | $39.08 | 2023-2025 | Watchpatone |
| Glaxosmithkline, LLC. | $35.94 | 2025 | Nucala |
| Neurent Medical Limited | $29.83 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Phadia US INC. | $18.82 | 2024 | Immunocap |
| Genzyme Corporation | $17.21 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $13.78 | 2024 | Ajovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Boone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.